Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019



Jasper  Bos

Jasper Bos

Vice President and Head of Healthcare, Merck Ventures
Jasper Bos, PhD joined the previous biopharma fund MS Ventures in 2009 and transitioned to Vice President leading the Healthcare team for the current fund in 2016. Previously, Jasper was instrumental in the founding of IFHA, Investment Fund for Health in Africa, a private equity fund backed by large Dutch and international institutional investors. He was responsible for the structuring and capital raise of IFHA and negotiated and managed private equity investments in emerging economies in the healthcare and insurance sectors. Before IFHA, Jasper worked as health economics and strategy manager at the Netherlands Vaccine Institute. He holds a PhD in Pharmacy from the University of Groningen, the Netherlands and has published more than 30 articles on health economics and vaccines.
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd